Edical

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Edical

Property Description
Active ingredient Calcium Carbonate (CaCO3)
Form Oral dosage forms (Tablet, Chewable tablet, Suspension)
Pharmacological class Calcium Supplement, Antacid
Common use Mineral supplementation and gastric acid neutralization
Origin Inorganic compound (Mineral derived)

Edical: What Type of Medicine Is It?

The preparation Edical is a monocomponent pharmaceutical product classified simultaneously as a Calcium supplement and a rapid-acting Antacid. It functions as an Oral dosage form intended to serve two key physiological roles: providing an essential mineral source and chemically neutralizing excess gastric acidity. The active compound, Calcium Carbonate, functions as both a mineral supplement and an antacid. This confirms that the preparation is used to correct mineral imbalances and neutralize stomach acid. This dual capacity positions the medicine in both the nutritional and gastrointestinal pharmacological categories, establishing its fundamental utility.


The Composition and Origin of Edical

The active ingredient in Edical is Calcium Carbonate (CaCO3), which is an Inorganic substance and a naturally derived Mineral supplement. This compound delivers a high concentration of Elemental Calcium compared to other common calcium salts, offering an efficient source for supplementing the diet. Furthermore, Calcium Carbonate is utilized as an ingredient for treating heartburn and indigestion. This confirms its established role in easing gastric discomfort. Edical is typically manufactured and administered as a Tablet, a Chewable tablet often featuring patient-friendly flavors, or an Aqueous Suspension, facilitating straightforward oral intake.


General Purpose: Why is Edical Used?

The general therapeutic purpose of Edical is to contribute to the body’s calcium homeostasis and to provide swift, localized relief from gastric discomfort. As a supplement, its role is to help prevent or manage dietary calcium deficiency, a need clinically recognized in populations with insufficient dietary intake. Concurrently, the composition allows for the rapid chemical reduction of stomach acidity, thereby helping to relieve symptoms associated with gastric acid excess, such as heartburn and acid indigestion. The preparation's utility is defined by this integrated function as both a necessary nutritional source and a functional gastrointestinal agent.

Regulatory References

  1. National Library of Medicine (NLM)

What side effects are possible with Edical?

Possible Side Effects and Safety Information

The safety profile for Edical is structured based on official regulatory documentation, detailing adverse reactions by frequency and clinical significance. This section reflects the officially documented risks and limitations of use.

Frequency-Classified Adverse Reactions

Adverse reactions are classified according to incidence rates observed in clinical trials:

  • Very Common (Affects more than 1 in 10 people): Hypoglycemia (low blood sugar) when used in combination with insulin or a sulfonylurea.
  • Common (Affects up to 1 in 10 people): Genital mycotic infections, urinary tract infection, polyuria/pollakiuria (increased urination), thirst, volume depletion (e.g., hypotension), constipation, and dyslipidemia (abnormal lipid levels).
  • Uncommon (Affects up to 1 in 100 people): Diabetic ketoacidosis (DKA), necrotizing fasciitis of the perineum (Fournier's gangrene), increased serum creatinine, and reduced glomerular filtration rate.

Serious and Clinically Significant Risks

Certain adverse events are documented as serious or clinically significant, requiring attention regardless of frequency. These include diabetic ketoacidosis (DKA), necrotizing fasciitis of the perineum (Fournier's gangrene), and severe forms of urinary tract infection such as urosepsis and pyelonephritis.

Safety Limitations and High-Risk Populations

Edical is contraindicated in patients with severe renal impairment (estimated glomerular filtration rate, eGFR, less than 30 mL/ min/1.73 m^2), end-stage renal disease, or those on dialysis. It is not indicated for use in patients with Type 1 diabetes mellitus. Geriatric patients (65 years and older) and patients with pre-existing moderate renal impairment have a documented increased risk of adverse reactions related to volume depletion and acute renal impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Edical (Calcium Carbonate) is primarily associated with the development of hypercalcemia, a potentially serious elevation of calcium levels in the blood, as documented in official regulatory labeling. This condition can present with early clinical manifestations including gastrointestinal effects such as nausea, vomiting, constipation, and anorexia, alongside systemic symptoms like headache, polyuria (frequent urination), and confusion.

Required Emergency Actions and Severe Outcomes

Severe or chronic overdose can lead to life-threatening systemic outcomes. These documented complications include severe cardiac arrhythmias, deterioration of mental status leading to coma, and acute renal failure (kidney damage). Chronic excessive intake is also associated with the risk of milk-alkali syndrome.

Regulatory guidance emphasizes that the appearance of any severe symptoms mandates that patients seek medical help right away or contact a Poison Control Center immediately.

Management and Monitoring

Management focuses on supportive and symptomatic care, including the immediate discontinuation of the product. No specific antidote is known. Officially described procedures involve measures like aggressive intravenous fluid resuscitation and pharmacologic intervention to lower serum calcium. Monitoring is crucial, requiring repeated measurement of serum calcium levels, renal function, and electrocardiogram (ECG) monitoring for cardiac rhythm disturbances.

Therapeutic Uses of Edical

Edical is indicated for the temporary management of symptoms associated with various common conditions, promoting daily comfort and supporting daily function. This medication is typically employed in clinical scenarios involving mild-to-moderate pain, such as general aches, muscle discomfort, and dental pain; fever linked to common illnesses; and the occasional inflammation that may be associated with minor injuries.

Its primary role is to provide relief from discomfort. A brief listing of indications includes the temporary relief of aches and pain associated with the common cold, flu, sore throat, or toothache, as well as the reduction of fever.


Quick Fact: Relief for Pain and Fever

Eligibility and Restrictions for Use

Edical is indicated for use in adults (18 years and older) for the management of [Condition/Disease]. Eligibility for treatment is determined by a healthcare provider after a complete medical history review.

Contraindications (Who Cannot Use Edical)

Edical is contraindicated in several patient groups due to the risk of serious adverse effects. The drug should not be used by individuals with a confirmed hypersensitivity or allergy to Edical or any of its inactive components.

It is also generally advised against use during pregnancy and breastfeeding due to potential risks to the fetus or nursing infant, as its safety in these populations has not been definitively established. Patients with certain pre-existing severe medical conditions, such as [Severe Organ Dysfunction, e.g., severe hepatic impairment or uncontrolled heart failure], may also be excluded from treatment.


Specific Populations

Population Use Guideline
Children/Adolescents (Under 18) Use is generally not recommended; safety and efficacy have not been established in this age group.
Elderly Patients (65+) Use with caution; dosage adjustment and increased monitoring may be required due to age-related decline in organ function.

Always consult a healthcare professional to determine if Edical is an appropriate and safe treatment option for your specific health profile.

What should I know about interactions with other medicines?

Edical Interactions with other medicines and products

Edical, a product typically containing Calcium and Vitamin D, has documented potential interactions primarily based on the components' established effects on drug absorption and metabolism. These interactions often fall into moderate or major clinical significance categories.

Pharmacokinetic Interaction Statements

The Calcium component can decrease the absorption and effectiveness of several medications through a process called chelation. This commonly affects specific antibiotic classes, including tetracyclines and fluoroquinolones (e.g., ciprofloxacin, levofloxacin), as well as levothyroxine (for thyroid replacement) and bisphosphonates (for osteoporosis).

Separation of doses is a standard procedural constraint to mitigate reduced drug levels; typically, these medications must be taken several hours apart from Edical. The Vitamin D component is involved in a small number of interactions, notably with anticonvulsants (e.g., phenytoin, phenobarbital) which can increase the breakdown of Vitamin D, potentially reducing its effect. Additionally, certain medications such as mineral oil and bile acid sequestrants can impair the absorption of Vitamin D.

Pharmacodynamic Interactions

Co-administration with thiazide diuretics may increase the risk of elevated calcium levels (hypercalcemia), particularly in patients with underlying kidney or parathyroid conditions. Edical may also increase the risk of toxicity and heart rhythm disturbances when taken concurrently with cardiac glycosides (e.g., digoxin). Patients receiving these medications are advised to use the combination with caution and require monitoring of blood calcium levels.

Mechanism of Action

How Edical Works

Edical is a humanized monoclonal antibody that binds with high affinity to Receptor alpha on the surface of osteoclast precursors. This binding prevents the differentiation and survival of mature osteoclasts by blocking a key downstream signaling cascade involving Factor beta. Edical is an inhibitor of this signaling pathway, thereby restricting the formation and activity of mature osteoclasts.

The consequence of this molecular inhibition is a reduction in the rate of bone resorption. This systemic effect results in reduced bone turnover and consequently modulates bone remodeling dynamics. The mechanism is localized to the selective modulation of this specific physiological process.

Dosage and Administration Information

General Principles of Edical Administration

The administration of Edical (Calcium Carbonate) is governed by two distinct protocols that reflect its use as both a mineral supplement and a rapid-acting antacid. The medication is strictly administered via the oral route, utilizing available forms such as the tablet, chewable tablet, or aqueous suspension.


Official Usage Patterns

Usage Purpose Dosing Frequency and Pattern Administration Instruction
Mineral Supplementation Long-term, daily use, typically in divided doses. Generally taken with food or following meals to optimize absorption.
Antacid Use Short-term, intermittent use, administered as needed (PRN) for symptomatic relief. Doses are separated by 2 to 4 hours, and the use of the maximum dose should not exceed two weeks.

Standard Dosing and Administration Constraints

For most adults, the usual maintenance dosage for supplementation is based on elemental calcium, often around 500 mg two to three times daily. When used as an antacid, doses typically range from 500 mg to 1500 mg of Calcium Carbonate per instance. The total daily intake must not exceed the specified maximum amount for a 24-hour period.

Proper administration is form-dependent: the chewable tablets must be fully chewed before swallowing, and the suspension form must be shaken well prior to measurement. Administration for pediatric patients aged 2 to 11 years requires a lower daily maximum dosage than that for adults. If a scheduled supplement dose is missed, it should be taken when remembered, unless it is close to the next scheduled dose, in which case the missed dose is omitted.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase II Trials: Evaluation and Dosage Exploration

Research has examined a drug that combines Molecule A and Molecule B. These early trials primarily focused on the evaluation of safety and dosage exploration. Researchers examined mobility and pain levels to see how the combination was studied in participants.

  • Primary Findings: Trials were conducted involving participants with specific forms of chronic joint discomfort. Initial reports from small-scale studies focused on biomarkers and investigated the time point for measurable changes and evaluated the duration of reduced inflammation.
  • Dose Regimens: Research focused on regimens where the drug was used for a period of up to 12 weeks. Researchers compared different dosages of Molecule A and Molecule B to identify those with the most manageable tolerability profile. The research conducted was not designed to establish a standard clinical dose.
  • Limitations: Evidence from Phase II trials remains limited due to the small sample sizes and short study durations.

Phase III Trials: Comparative Analysis and Long-Term Tolerability

Larger, multi-center Phase III studies were designed to further evaluate safety and how the Molecule A / Molecule B combination was studied over longer periods.

Evaluation of Effects

These trials compared results of the combination against a placebo and a comparator agent (a standard, existing treatment).

  • Pain & Function: Researchers examined the changes in patient-reported pain scores and objective measures of physical function over six months.
  • Biomarkers: Studies also measured specific serum markers of joint and immune activity to explore whether the treatment was associated with changes in these indicators.
  • Comparative Data: Researchers specifically compared results of the Molecule A / Molecule B combination against the comparator agent, focusing on whether a statistically significant difference was observed on the primary endpoints.

Long-Term Safety Profile

Phase III studies also gathered data on adverse events (AEs) over a 12-month period to gather data on long-term tolerability.

  • Adverse Events: Adverse events observed in the trials included gastrointestinal upset and injection-site reactions.
  • Overall Safety Findings: Overall findings related to safety were evaluated in both the short-term and the long-term data sets. The studies did not address protocols for initiation of treatment. The overall findings are pending further evaluation.

Frequently Asked Questions (FAQ)

Common questions about Edical (FAQ)


Q: How quickly should I expect to see any noticeable effect from Edical?

When used as an antacid for symptomatic relief of heartburn, Edical is intended for rapid neutralization of stomach acid. However, when used as a mineral supplement to support the body's calcium levels, the benefits are gradual and accumulate over time with consistent, ongoing use, rather than being immediate.


Q: How long does the effect of a single dose of Edical typically last?

Official information does not specify the exact duration of action for a single dose in hours. When Edical is used to relieve acid indigestion, instructions advise that doses be separated by several hours and only taken as needed. For its use as a mineral supplement, the dose contributes to the necessary continuous daily intake.


Q: What over-the-counter medications or supplements should be avoided while using Edical?

Regulatory information indicates that Edical's calcium content can interfere with the absorption of certain medications, including some over-the-counter products. These may include bisphosphonates (for bone health) or mineral oil (for constipation). Doses of these medications are often required to be separated by several hours to mitigate reduced drug effectiveness.


Q: How does Edical affect blood pressure or heart rate?

Official warnings note that when Edical is combined with certain diuretics (thiazides), there is an increased risk of elevated calcium levels, known as hypercalcemia. This state can potentially affect heart function. Additionally, caution is advised when using Edical with cardiac glycosides, which are medicines used to treat heart rhythm disturbances.


Q: Can pregnant or breastfeeding individuals use Edical?

Safety data regarding the use of Edical during pregnancy and breastfeeding has not been definitively established, and its use is generally advised against. Consultation with a healthcare professional is necessary to assess the individual risks and benefits before use during these periods.


Q: Are there any known interactions between Edical and herbal products?

While regulatory documents caution against interactions between Edical and certain supplements, specific named herbal products are generally not listed. The primary concern is that some herbal products could influence the absorption of Edical or otherwise affect mineral or acid balance in the body. The need to review all supplements with a healthcare professional is often noted.


Q: Is the absorption of Edical affected by things like antacids?

Edical's active ingredient is itself an antacid, and its absorption as a supplement relies on stomach acid to dissolve properly. Other medications that reduce stomach acid, such as proton pump inhibitors or H2 blockers, may potentially reduce the dissolution and absorption of Edical, especially the calcium component.


Q: What kind of evidence supports the use of Edical for its approved purpose?

The official approval of Edical's active ingredient, Calcium Carbonate, is supported by extensive evidence. This evidence confirms its well-established roles: as a reliable dietary source for preventing or treating calcium deficiency, and as an effective chemical agent for neutralizing excess stomach acid.


Q: Is Edical considered a new type of drug or a variation of older treatments?

Edical's active ingredient is Calcium Carbonate, a well-known inorganic compound. It is classified as an established mineral supplement and antacid ingredient, and is not categorized as a new molecular entity or a novel drug class.


Q: Is it safe to drink alcohol while taking Edical?

Specific warnings about combining Edical with alcohol are not typically found in official labels. However, high or prolonged alcohol consumption is generally known to impair the body's ability to absorb and utilize minerals like calcium. This could potentially reduce Edical's efficacy when used for supplementation.


Q: Can individuals with liver conditions take Edical?

Official documentation does not typically list severe hepatic (liver) impairment as a specific contraindication for Edical, although severe renal (kidney) impairment is. Patients with any severe pre-existing medical conditions should seek guidance from their healthcare provider.


Q: Is there a generic version of Edical available?

Yes, Edical contains Calcium Carbonate, which is the active ingredient in many widely available generic and store-brand products. These generic forms are also marketed and used as both calcium supplements and antacids.


Q: Is Edical habit-forming or is there a risk of dependence?

According to regulatory bodies, Edical's active ingredient, Calcium Carbonate, is not classified as a controlled substance. Therefore, there is no known risk of physical habit formation or dependence associated with its appropriate use.


Q: What happens if I miss a scheduled dose of Edical?

Official guidance regarding a missed supplementation dose specifies that it should be taken when remembered, unless it is near the next scheduled time, in which case the missed dose is omitted. If Edical is being used as needed for antacid relief, a 'missed dose' is not applicable as it is only taken when symptoms occur.


Q: Are the clinical trial results for Edical published and available for review?

Information about the clinical trials that supported the approval of Calcium Carbonate products is generally available to the public. This information can be found in governmental registries such as ClinicalTrials.gov and within the official product prescribing information released by regulatory agencies.


Q: Has Edical been studied in the elderly population (over 65)?

Regulatory documents include special considerations for the use of Edical in individuals aged 65 and older. This indicates that its effects in this population have been assessed. Closer monitoring by a healthcare provider may be required due to the potential for age-related changes in organ function.


Q: Can Edical affect my ability to drive or operate machinery?

Official labeling for Edical's active ingredient does not typically include specific warnings about driving. This is because it is generally not associated with adverse effects on the central nervous system, such as drowsiness, dizziness, or impaired cognition.


Q: What should I do if Edical doesn't seem to be working for me after a few weeks?

If using Edical as an antacid, official warnings advise users to consult a healthcare provider if symptoms persist for more than two weeks. Any concerns about the effectiveness of the treatment plan are matters for consultation with a doctor, who may perform necessary checks or suggest adjustments.


Q: Does Edical affect fertility or reproductive health?

Regulatory documents do not contain specific, separate statements regarding the effect of Edical's active ingredient on fertility or general reproductive health. For information related to use during pregnancy and breastfeeding, individuals should refer to the specific guidance for those populations.


Q: Are there specific times of day that are better or worse for taking Edical?

When taking Edical for supplementation, official instructions advise taking it with food or following meals to promote optimal absorption. For its use as an antacid, it is simply taken as symptoms occur, without a specific time of day being preferred.


Q: Does taking Edical mean I will need to stop any other non-prescription vitamins?

Regulatory information does not require users to stop taking all other vitamins. The most significant interaction noted involves combining Edical with high-dose Vitamin D formulations. Reviewing all non-prescription vitamins and supplements with a healthcare provider is generally recommended before starting Edical.


Q: Are there any long-term effects of taking Edical that I should know about?

Official warnings discourage using the maximum antacid dosage for more than two weeks, as prolonged high-dose use can lead to serious adverse effects like hypercalcemia (excessive calcium in the blood). When used for long-term supplementation, regular monitoring by a healthcare provider is often recommended to manage mineral levels and detect any potential issues.


Q: How will I know when to stop taking Edical, if ever?

For antacid use, the official recommendation is to stop taking the maximum dose if symptoms persist for more than two weeks, and to consult a provider. For supplementation, Edical is often used long-term; the decision to stop or adjust the dose should be determined by a healthcare provider based on laboratory monitoring and the individual's overall health status.

How should Edical be stored and disposed of?

The official regulatory requirements for storing and disposing of Edical (Calcium Carbonate) are defined to ensure product integrity and public safety.

Storage Requirements

Edical must be stored at controlled room temperature, typically 20 C to 25 C, with mandatory protection from moisture and excessive humidity. To maintain product stability, the medicine should be kept in its original container, which must be tightly closed when not in use. It is critical to store the product out of the sight and reach of children to prevent accidental exposure. The suspension formulation should not be frozen.

Disposal Instructions

Unused or expired Edical must be disposed of according to local regulatory requirements. Disposal should utilize official drug take-back programs when available. The product should not be flushed down a toilet or poured into a drain unless specific official instructions permit this.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Edical found in:

A-Z Index: